Department of Clinical Medicine, Institute of Tropical Medicine, Nagasaki University, Japan.
Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences, Japan.
Intern Med. 2023 Jul 15;62(14):2145-2149. doi: 10.2169/internalmedicine.0782-22. Epub 2022 Dec 7.
A prolonged activated partial thromboplastin time (APTT) is observed in patients with severe fever with thrombocytopenia syndrome (SFTS) and is one of the risk factors for severe disease. The mechanism underlying a prolonged APTT is largely unknown. The presence of antiphospholipid (aPL) antibodies in various viral infections has been documented but never reported in a patient with SFTS. We herein report the first SFTS patient with APTT prolongation and concurrent transiently positive aPL antibodies (lupus anticoagulants and anticardiolipin antibodies) with no coagulation factor deficiency.
在伴有发热伴血小板减少综合征(SFTS)的患者中,活化部分凝血活酶时间(APTT)延长较为常见,这是导致疾病加重的一个危险因素。APTT 延长的机制目前尚不清楚。在各种病毒感染中存在抗磷脂(aPL)抗体已被证实,但在 SFTS 患者中从未报道过。本研究报道了首例伴有 APTT 延长且无凝血因子缺乏的 SFTS 患者,其抗磷脂抗体(狼疮抗凝物和抗心磷脂抗体)一过性阳性。